3 курс / Общая хирургия и оперативная хирургия / Бронхолегочные_осложнения_хронического_лимфолейкоза_и_множественной

hematologic malignancies // Am. J. Roentgenol. – 2003. – Vol. 181, N 2.

– P. 507–518.

378. Orchard K., Barrington S., Buskombe J. Fluorodeoxyglucose positron emission tomography imaging for the detection of occult disease in multiple myeloma // Br. J. Haematol. – 2002. – Vol. 117. – P. 133–135.

379.Osserman E.F., Di Re L.B. Identical twin marrow transplantation in multiple myeloma // Acta Hematol. – 1982. – Vol. 68. – P. 215– 223.

380.Pahor A. L. Plasmacytoma of the Larynz // J. Laryng. – 1978. – Vol. 92, N 3. – P. 225–232.

381.Panidis J.P., Ross J., Mintz G.S. The effect of sampling site on the assessment of pulmonary blood flow by doppler echocardiography

//10 World Congress of Cardiology, Washington, 14-19 Sept. 1986. – Washington, 1986. – P. 277.

382.Pastor F.J. Guarro J. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections // Clin. Microbiol. Infect. – 2006. – Vol. 12, N 10. – P. 948–960.

383.Acute leukemia of plasmablastic type as terminal phase of multiple myeloma / L. Piccinini [et al.] // Haematologica. – 2002. – Vol. 87. – P. 4.

384.Sur les manifestations T.F. thoraciques au cours de la maladie de Kahle / R. Pieron [et al.] // Poumon. – 1972. – Vol. 28, N 8. – P. 427–434.

385.Piragine F. I. Рlasmocitomi solitari extramidollari nei distretti O.R.L. // Atenco parmensc. – 1974. – Vol. 45, N 3. – P. 131–144.

386.Polizzotto M.N., Tam C.S., Milner A. The influence of increasing age on the deliverability and toxity of fludarabine-based combination chemotherapy regiment in patients with indolent limfoproliferative disorders // Cancer. – 2006. – Vol. 107, N 5, Aug. 15. – P. 773–780.

387.Rai K.R., Savitsky A., Crenkite E.P. Clinical staging of chronic lymphocytic leukemia // Blood. – 1975. – Vol. 46. – P. 219–234.

388.Rajkumar, S.V. Ask the Expert // Myeloma Focus. – 2002. – Vol. 3. – P. 43–48.

389.Rajkumar S.V., Hauman S., Gertz M.A. Combination therapy with thalidomide plus dexamethasone fo newly diagnosed myeloma // J. Clin. Oncol. – 2002. – P. – 4319 – 4323.

301

390.Remy-Jardin M., Jiraud F., Remy J. Importance of graundglass attenuation in chronic infiltrative lung disease-pathologic CT correlation // Radiology. – 1993. – 1989. – P. 603–698.

391.Rochester D.F. Respiratory muscles and ventilatory failure: 1993 perspective // Am. J. Med. Sci. – 1993. – Vol. 305. – P. 394–402.

392.Rodriguez C., Lujan-Zilbermann J., Woodard P. Successful treatment of disseminated fusariosis // Bone Marrow Transplant. – 2003.

–Vol. 31. – P. 411–412.

393.Rollins S D., Colby T.V. Lung biopsy in chronic lymphocytic leukemia // Arch . Pathol. Lab. Med. – 1988. – Vol. 112, N 6, Jun. – P. 607–611.

394.Rome L., Murali G. , M. Lippmann Nonresolving pneumonia and mimics of pneumonia // Med. Clin. Am. – 2001. – N 85. – P. 1511–1530.

395.Sadek S.A. Plasmacytoma of the nasopharynx // J. Laryngol otol. – 1985. – Vol. 99, N 12. – P. 1289–1292.

396.Santra M.A., Zhan F., Tian E. Subsect of multiple myeloma harboring the t(4; 14) (p16; q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript // Blood. – 2003. – Vol. 101. – P. 2374–2376.

397.Farnesyltransferase Inhibitors and Their Role in the Treatment of Multiple Myeloma / R Santucci [et al.] // Cancer Control. – 2003.

–Vol. 10. – P. 384–388.

398.Sanz L., Blade J., Olondo M. Contribution of magnetic resonance to the differential diagnosis of a collapsed vertebra in a patient with multiple myeloma // Sangre (Bark). – 1998. – Vol. 43. – P. 77–81.

399.Saubolle M.A., Saubolle M.A., Sussland D. Nocardiosis: review of clinical and laboratory experience // J. Clin. Microbiol. – 2003.

–Vol. 41. – P. 4497– 4501.

400.Schulmmer P., Heise D. Die klinische konseguenz des Euler lifiesraud mechanism bei obstruktiver ventilationsstorueg // Therapiewoche. – 1984. – Bd. 34, N 47. – S. 6718–6726.

401.Schulz H., Rehward U. Phase 2 study of combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia // Blood. – 2002. – Vol. 10. – P. 3115–3120.

402.Schulz H., Wendtner C.M., Bergmann M. Fludarabine combination therapy for the treatment of chronic lymphocytic leukemia // Clin. Lymphoma. – 2002. – Vol. 3. – P. 26–35.

403.Schwaenen C., Nessling M., Wessendorf S. Automated ar-

302

ray-based genomic profiling in chronic lumphocytic leykemia: Development of a clinical tool and discovery of recyrrent genomic alterations // Proc. Natl. Acad. Sci. USA. – 2003. – Vol. 101. – P. 1039–1044.

404.Seneterre E., Paganin F., Bruel J.M. Measurement of the internal size of bronchi high resolution computed tomography // Eur. Respir. J. – 1994. – Vol. 7. – P. 596–600.

405.Siafakas N. M. ERS Consensus Statement: optimal assessment and management of chronic obstructive pulmonary disease // Eur. Respir. Rev. – 1996. – Vol. 6, N 39. – P. 270–275.

406.Singhal S. Hight-dose therapi and autologous transplantation

//Myeloma. – 2002. – 2002. – P. 327 – 347.

407.Sekulich M., Pandola A. Solitary pulmonary mass multiple myeloma // Dis. chest. – 1965. – Vol. 48, N 1. – P. 100–103.

408.Slungaard A., Smith M.J. Serum immunoglobulin levels in chronic lymphatic leukemia // Scand. J. Haematol. – 1974. – Vol. 12, N 2. – P. 112–116.

409.Sontar C. A. Distribution of Plasma Cells and other Cells Containing. Immunoglobulin in the Respiratory Tract in Chronic Bronchitis // Thorax. – 1977. – Vol. 32, N 4. – P. 387–396.

410.Spenser А. The pulmonary plasma cell (histiocytoma complex) / Spenser // H. Histopathology. – 1984. – Vol. 8, N 6. – P. 903–916.

411.Spicka I., Klener P. Multiple Myeloma – clinical symptoms, diagnosis, prognosis, therapy // Cas. Lek. Cesk. – 2000. – Vol. 139. – P. 391–395.

412.Spicka I., Cieslar P., Prochazka B. Prognostic factors and marcers of activity in multiple myeloma (results of the Cooperative Group for Diagnosis and treatment of Multiple Myeloma) // Cas. Lek. Cesk. – 2000. – Vol. 139. – P. 208–212.

413.Stevens D., Kan V., Jidson M. Practice guidelines for diseases caused by Aspergillus // Clin. Inf. Dis. – 2000. – Vol. 30. – P. 662–679.

414.Computed tomography in adult obliterative bronchiolitis / M.C. Sweatman [et al.] // Clin. Radiol. – 1990. – Vol. 41. – P. 116–119.

415.Tenholder M.J., Scialla S.J., G. Weisbaum Endobronchial metastatic plasmacytoma // USA Cancer. – 1982. – Vol. 49, N 7. – P. 1465–1468.

416.Terwort H. Endotracheal gelegenes Plasmacytom // Fortschr. Rontgesstr. – 1973. – Vol. 119, N 3. – P. 361–362.

417.Thibault Ph. Les manifestations Thoraciques au cours des

303

hemopathies // Press med. – 1971. – Vol. 79, N 1. – P. 9–10.

418.Attemts at measuring pulmonary arterial pressure by means of Doppler echocardiography in patients with chronic lung disease / A. Torbieki [et al.] // Eur. Respir. J. – 1989. –Vol. 2, N 9, Oct. – P. 856– 860.

419.Traver G.A., Cline M.G., Buzzow B. Predictors of mortality in chronic obstructive pulmonary disease: a 15 years follow-up study // Am. Rev. Respir. Dis. – 1979. – Vol. 119. – P. 895–902.

420.Treves R., Guionic J.P., Desproges-Gotteren R. Localisations extra-ossenses du myeloma epanchements pleuraux et atteinte cutance // Rhymatologie. – 1979. – Vol. 31, N 3. – P. 89–94.

421.Tuddenham E.G.D., Whittaker J.A., Bradley J. Hyperviscosity syndrome in IgA multiple myeloma // Brit. J. Haematol. – 1974. – Vol. 27, N 1. – P. 65–76.

422.T-cell chronic lymphocytic leukaemia with pulmonary involvement and relapsing BOOP / E. Vaiman [et al.] // Eur. Respir. J. – 1999. – Vol. 14, N 2. – P. 471–475.

423.Valdivia E., Hensley G., Wn J. Morphology and Pathogenesis of Desquamative Interstitial Pneumonitis // Torax. – 1977. – Vol. 32, N 1. – P. 7–18.

424.Vasconcelos Y., Davy F., Levy V. Binet’s stading system and VH genes are independent but complementory prognostic indicators in chronic lymphocytic leukemia // J. Clin. Oncol. – 2003. – Vol. 21. – P. 3928– 3932.

425.Multiple myeloma and chronic lymphocytic leukemia / R. Vescio [et al.] // Curr. Opin. Hematol. – 1996. – Vol. 3, N 4. – P. 288– 296.

426.Vesin P., Naousy J., Kunzler Les epenchements pleuraux au cours du myelome dissemine // Medl. int. – 1976. – Vol. 52, N 12. – P. 765–768.

427.Vidal J., Pages A., Michel Les epanchements de l’appareil respiratioire // J. Med. Lyon. – 1969. – Vol. 34. – P. 589–603.

428.The cardiopulmonary unit. The body’s gas transport system /

K. T. Weber [et al.] // Clin. Chest. Med. – 1983. – Vol. 4, N 2. – P. 101– 110.

429.Wierda W., S. O’Brian, S. Wen Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refracto-

304

ry chronic lymphocytic leukemia // J. Clin. Oncol. – 2005. – Vol. 23. – P. 4070–4078.

430.Respiratory syncytial virus, airway inflammation, and fev1 decline in patients with chronic obstructive pulmonary disease / T. M. A. Wilkinson [et al.] // Am. J. Respire. Crit. Care Med. – 2006. – Vol. 173. – P. 871–876.

431.Pulmonary arterial hypertension and emphysema / I. P. Williams [et al.] // Brit. J. Dis. Chest. – 1984. – Vol. 78, N 3. – P. 211–216.

432.Whipp B. J. Ventilatory control during exercive in humans // Ann. Rev. Physiol. – 1983. – Vol. 45. – P. 393.

433.The structure and function of the pulmonary vasculature in midl chronic obstructive pulmonary disease. The effect of oxygen and exercise / I.L. Wright [et al.] // Amer. Rev. Resp. Dis. – 1983. – Vol. 128, N 4. – P. 702–707.

434.Zham F., Hardin J., Kordsmeier B. Global gene expression profiling of multiple myeloma, monoclonal gammapathy of indeterminet significance, and normal bone marrow plasma cels // Blood. – 2002. – P. 1745 – 1757

435.Zomas A., Dimopoulos M.A Conventional treatment of myeloma // Myeloma. Eds. Mehta J. and Singhal S. London: Martin Dunitz. – 2002. – P. – 313 – 326.

305